These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2568052)

  • 1. Etiology of vitiligo. A new hypothesis.
    Ramaiah A; Puri N; Mojamdar M
    Acta Derm Venereol; 1989; 69(4):323-6. PubMed ID: 2568052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation.
    Abdel-Naser MB; Hann SK; Bystryn JC
    Arch Dermatol; 1997 Dec; 133(12):1530-3. PubMed ID: 9420537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term effects of acetylsalicylic acid treatment on the proliferation and lipid peroxidation of skin cultured melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Nov; 25(11):1656-63. PubMed ID: 15573197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth defects of melanocytes in culture from vitiligo subjects are spontaneously corrected in vivo in repigmenting subjects and can be partially corrected by the addition of fibroblast-derived growth factors in vitro.
    Puri N; Mojamdar M; Ramaiah A
    Arch Dermatol Res; 1989; 281(3):178-84. PubMed ID: 2774645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of localized vitiligo by autologous minigrafting.
    Falabella R
    Arch Dermatol; 1988 Nov; 124(11):1649-55. PubMed ID: 3052304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful culture of adult human melanocytes obtained from normal and vitiligo donors.
    Medrano EE; Nordlund JJ
    J Invest Dermatol; 1990 Oct; 95(4):441-5. PubMed ID: 1698887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical findings and therapeutic methods in vitiligo. Patient's own melanocytes produce new pigmentation].
    Olsson MJ; Juhlin L
    Lakartidningen; 1995 Mar; 92(13):1341-4. PubMed ID: 7707778
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of acetylsalicylic acid on the release rates of leukotrienes B4 and C4 from cultured skin melanocytes of active vitiligo.
    Zailaie MZ
    Saudi Med J; 2004 Oct; 25(10):1439-44. PubMed ID: 15494818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitiligo: current medical and scientific understanding.
    Boissy RE; Nordlund JJ
    G Ital Dermatol Venereol; 2011 Feb; 146(1):69-75. PubMed ID: 21317859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in vitro and patients with vitiligo in vivo.
    Wu CS; Lan CC; Wang LF; Chen GS; Wu CS; Yu HS
    Br J Dermatol; 2007 Jan; 156(1):122-9. PubMed ID: 17199578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant Notch signaling: a potential pathomechanism of vitiligo.
    Diao JS; Zhang X; Xia WS; Zheng Y; Ren J; Wang YM; Gong Z; Xia W; Guo SZ
    Med Hypotheses; 2009 Jul; 73(1):70-2. PubMed ID: 19269111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo.
    van Geel N; Ongenae K; De Mil M; Haeghen YV; Vervaet C; Naeyaert JM
    Arch Dermatol; 2004 Oct; 140(10):1203-8. PubMed ID: 15492182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of the c-kit receptor by epidermal melanocytes may be reduced in vitiligo.
    Norris A; Todd C; Graham A; Quinn AG; Thody AJ
    Br J Dermatol; 1996 Feb; 134(2):299-306. PubMed ID: 8746346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare repigmentation pattern in a vitiligo patient: a clue to an epidermal stem-cell reservoir of melanocytes?
    Davids LM; du Toit E; Kidson SH; Todd G
    Clin Exp Dermatol; 2009 Mar; 34(2):246-8. PubMed ID: 18828846
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo].
    Rojas-Urdaneta JE; Poleo-Romero AG
    Invest Clin; 2007 Mar; 48(1):21-31. PubMed ID: 17432541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vitiligo].
    Njoo MD; Westerhof W
    Ned Tijdschr Geneeskd; 1997 Apr; 141(16):759-64. PubMed ID: 9213796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo.
    Abdallah M; Abdel-Naser MB; Moussa MH; Assaf C; Orfanos CE
    Eur J Dermatol; 2003; 13(6):548-52. PubMed ID: 14721774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Culture of melanocytes obtained from normal and vitiligo subjects.
    Im S; Hann SK; Park YK; Kim HI
    Yonsei Med J; 1992 Dec; 33(4):344-50. PubMed ID: 1309014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocyte transplantation for the treatment of vitiligo: effects of different surgical techniques.
    Issa CM; Rehder J; Taube MB
    Eur J Dermatol; 2003; 13(1):34-9. PubMed ID: 12609779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimelanoma immunity in vitiligo and melanoma patients.
    Juranic ZD; Stanojevic-Bakic N; Zizak Z; Babovic N; Radovic-Kovacevic V; Stanojkovic T; Dzodic R
    Neoplasma; 2003; 50(4):305-9. PubMed ID: 12937846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.